(Q41918630)

14 October 2017

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania (English)

1 reference

14 October 2017

0 references

0 references

Plasmodium falciparum

0 references

author name string

T Mutabingwa

1

1 reference

14 October 2017

A Nzila

2

1 reference

14 October 2017

E Mberu

3

1 reference

14 October 2017

E Nduati

4

1 reference

14 October 2017

P Winstanley

5

1 reference

14 October 2017

E Hills

6

1 reference

14 October 2017

W Watkins

7

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

14 October 2017

1 reference

14 October 2017

358

1 reference

14 October 2017

9289

1 reference

14 October 2017

1218-1223

1 reference

Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene

14 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Chloroquine treatment of falciparum malaria in an area of Kenya of intermediate chloroquine resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Trial of pyrethroid impregnated bednets in an area of Tanzania holoendemic for malaria Part 4. Effects on incidence of malaria infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Insecticide-impregnated bed nets reduce malaria transmission in rural Zanzibar.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Changing home treatment of childhood fevers by training shop keepers in rural Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Cost-effectiveness of malaria control in sub-Saharan Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

Averting a malaria disaster

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906344-9

7 January 2021

10.1016/S0140-6736(01)06344-9

Identifiers

DOI

1 reference

14 October 2017

1 reference